← back to search

Roberto Caporali

University of Milan · IT
🔎 Find collaborators in Rheumatology · Pathology and Forensic Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Rheumatology · Pathology and Forensic Medicine
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Systemic Sclerosis and Related Diseases, and Spondyloarthritis Studies and Treatments.
h-index
73
citations
22,594
works
852
NIH funding
primary concept
Medicine
email

Recent publications

Rethinking obesity, immunity, and the promise of anti-obesity therapies in PsA.
2026cited by 0position: contributordoi
Tocilizumab and Rituximab in Systemic Sclerosis: A Real-Life Retrospective Observational Study Across Different Clinical Phenotypes.
2026cited by 0position: contributordoi
Revisiting osteoarthritis as an inflammatory disease: characterization of synovitis grading and synovial pathotypes in surgical specimens.
2026cited by 0position: contributordoi
Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study.
2026cited by 0position: contributordoi
Epigenetic Modifications during Pregnancy in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Multicentre Study​
2026cited by 0position: contributordoi
Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study
Rheumatology and Therapy 2026cited by 0position: middledoi
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study.
2025cited by 5position: contributordoi
Exploring relief for Behçet's disease refractory oral ulcers: a comparison of TNF inhibitors versus apremilast.
2025cited by 4position: contributordoi
Anti-neutrophil cytoplasmic antibodies associated interstitial pneumonia: A possible new clinical entity.
2025cited by 2position: contributordoi
If the evidence is there, why are GLP-1 receptor agonists not on-label for hip and knee osteoarthritis in overweight patients?
2025cited by 0position: contributordoi
Integrating Nutrition into Precision Medicine for Controlling Systemic Inflammation in Rheumatoid Arthritis.
2025cited by 0position: contributordoi
Expanding the expanded risk score to psoriatic arthritis: any port in a storm.
2025cited by 0position: contributordoi
Effectiveness and safety of upadacitinib in juvenile idiopathic arthritis: beyond the polyarticular subset in pediatric and adult patients.
2025cited by 0position: contributordoi
Results of an expert Delphi consensus from the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Rheumatology (SIR) on standardized requesting and reporting magnetic resonance imaging in patients with suspected or known axial spondyloarthritis
La radiologia medica 2025cited by 0position: middledoi
Correction: Results of an expert Delphi consensus from the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Rheumatology (SIR) on standardized requesting and reporting magnetic resonance imaging in patients with suspected or known axial spondyloarthritis
La radiologia medica 2025cited by 0position: middledoi
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study
RMD Open 2024cited by 19position: middledoi
Deciphering the clinical significance of longitudinal antiphospholipid antibody titers
Autoimmunity Reviews 2024cited by 11position: middledoi
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study.
2024cited by 11position: contributordoi
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years.
2024cited by 10position: contributordoi
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation
The Journal of Rheumatology 2024cited by 9position: middledoi
Owning Pets Reduces the Perception of Disease Activity in Patients With Rheumatoid Arthritis.
2024cited by 0position: contributordoi
Regulatory T-cells in multiple sclerosis produce IL-10 in the central 1 nervous system but are activated by Epstein-Barr Virus
2024cited by 0position: contributordoi
A case of Sjögren's syndrome presenting with conjunctival lymphoma
Clinical and Experimental Rheumatology 2024cited by 0position: middledoi
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients
Annals of the Rheumatic Diseases 2023cited by 36position: middledoi
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission
Autoimmunity Reviews 2023cited by 18position: middledoi
Safety of Janus Kinase Inhibitors: A Real-World Multicenter Retrospective Cohort Study.
2023cited by 12position: contributordoi
Subcutaneous Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis.
2023cited by 7position: contributordoi
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists
Frontiers in Medicine 2023cited by 4position: middledoi
POS0852 REAL LIFE DATA OF FILGOTINIB IN RHEUMATOID ARTHRITIS PATIENTS: DATA FROM ITALIAN GISEA REGISTRY
Annals of the Rheumatic Diseases 2023cited by 1position: middledoi
POS0862 PRESCRIPTION PATTERN OF JAK INHIBITORS OVER 5 YEARS IN ITALY: DATA FROM THE ITALIAN NATIONAL GISEA REGISTRY
Annals of the Rheumatic Diseases 2023cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 26 papers (2020–2026)Marcello Govoni · University of Ferrara18 papers (2012–2023)Ennio Giulio Favalli · CTO Hospital17 papers (2014–2025)Florenzo Iannone · University of Padua14 papers (2016–2024)Carlomaurizio Montecucco · University of Pavia14 papers (2013–2023)Fabrizio Conti · University of Ferrara12 papers (2014–2023) · 11 papers (2013–2023)Giovanni Lapadula · University of Ferrara11 papers (2013–2023)Elisa Gremese · University of Glasgow10 papers (2016–2023)Marco Sebastiani · University Hospital Frankfurt10 papers (2016–2024)Fabiola Atzeni · University of Aberdeen10 papers (2012–2023)Alberto Cauli · University of Cagliari10 papers (2018–2025)Gianfranco Ferraccioli · Centro Studi GISED9 papers (2016–2023) · 8 papers (2016–2024)Piercarlo Sarzi‐Puttini · University of Ferrara8 papers (2014–2018) · 7 papers (2014–2023)Roberto Gorla · University of Ferrara7 papers (2013–2023)Luca Cantarini · Misericordia University6 papers (2016–2025)Roberta Ramonda · University of Padua6 papers (2016–2019) · 6 papers (2018–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Rheumatology · Pathology and Forensic Medicine →